Pernova Hjälpmedel ABActive
Key figures
Key figures
2024/25Balance structure
Dividend
from the annual reportProposed dividend 200 000 kr.
Summary of annual reports2021–2025
| 2020/21 | 2021/22 | 2022/23 | 2023/24 | 2024/25 | |
|---|---|---|---|---|---|
| Balance sheet — assets | |||||
| Total current assets | 2 355 489 | 2 242 791 | 2 658 881 | 2 113 115 | 2 098 083 |
| Total non-current assets | 50 505 | 86 067 | 0 | 0 | 0 |
| Total assets | 2 405 994 | 2 328 858 | 2 658 881 | 2 113 115 | 2 098 083 |
| Balance sheet — liabilities and equity | |||||
| Current liabilities | 1 148 732 | 984 790 | 1 407 413 | 617 883 | 238 458 |
| Non-current liabilities | 856 998 | 1 193 816 | 930 517 | 799 507 | 744 315 |
| Total liabilities | 2 005 730 | 2 178 606 | 2 337 930 | 1 417 390 | 982 773 |
| Share capital | 100 000 | 100 000 | 100 000 | 100 000 | 100 000 |
| Retained earnings of previous periods | — | — | — | — | — |
| Profit for the year (equity) | −22 729 | −250 012 | −479 301 | 374 774 | 419 585 |
| Total equity | 400 264 | 150 252 | 320 951 | 695 725 | 1 115 310 |
| Income statement | |||||
| Sales revenue | 4 153 000 | 2 881 000 | 3 626 000 | 2 750 000 | 2 807 000 |
| Operating profit | 74 326 | −76 202 | −319 127 | 494 048 | 524 317 |
| EBITDA | 99 528 | −61 986 | −312 838 | 494 048 | — |
| Profit before income tax | −22 729 | −250 012 | −479 301 | 374 774 | 446 896 |
| Profit for the reporting year | −22 729 | −250 012 | −479 301 | 374 774 | 419 585 |
| Labour costs | 13 299 | 16 300 | 595 261 | 48 746 | 2 712 |
| Depreciation of non-current assets | 25 202 | 14 216 | 6 289 | 0 | — |
| Other indicators | |||||
| Employees | 1 | 1 | 1 | 1 | 1 |
| Proposed dividend | — | — | 0 | 0 | 200 000 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Similar companies
Summary: Pernova Hjälpmedel AB
Overview
Pernova Hjälpmedel AB (org. no. 556726-5755) is a limited company (AB). The company was registered in 2007 and has existed for 19 years. Registered seat: Luleå. Industry according to Statistics Sweden: wholesale of pharmaceutical and medical goods (SNI 46460).
Economy
Net sales in financial year 2025 were 2 807 000 kr, up 2,1 % on the previous year (2 750 000 kr). From 2021 to 2025, net sales declined by an average of 9,3 % per year. Net profit for 2025 was 419 585 kr (14,9 % of net sales). The company was profitable in 2 of the 5 reported financial years. Employees in financial year 2025: 1. Net sales per employee were 2 807 000 kr. At the end of financial year 2025, total assets were 2 098 083 kr and equity 1 115 310 kr (equity ratio 53,2 %). The annual report for 2025 proposes a dividend of 200 000 kr.
Sources and freshness
Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by 3 people. Data as of 2026-10-19. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.